How accurate is non‑invasive prenatal testing (NIPT) for detecting Down syndrome (trisomy 21) after 10 weeks’ gestation?

NIPT Accuracy for Down Syndrome Detection

NIPT detects Down syndrome (trisomy 21) with 98.8% sensitivity and an exceptionally low false-positive rate of 0.04%, making it the most accurate prenatal screening test available after 10 weeks' gestation. 1

Detection Performance

Sensitivity and Specificity:

• NIPT achieves a detection rate of 98.8% (95% CI = 97.8%-99.3%) for trisomy 21 in singleton pregnancies 1
• The false-positive rate is only 0.04% (95% CI = 0.02%-0.08%), meaning fewer than 1 in 2,000 unaffected pregnancies will screen positive 1
• In twin gestations, performance remains excellent with 98.2% sensitivity (95% CI = 88.2%-99.7%) and 99.9% specificity 1

Positive Predictive Value:

• The PPV for trisomy 21 is 91.8% (95% CI = 88.4%-94.23%) across various cohorts studied over the past 5 years 1
• In clinical practice, the PPV ranges from 50% to 95% depending on maternal age and population risk 1, 2
• This means that when NIPT returns positive for Down syndrome, there is a 50-95% chance the fetus is truly affected, compared to only 2.2-3.6% with traditional screening 1, 2

Comparison to Traditional Screening

NIPT vastly outperforms older screening methods:

• Traditional first-trimester combined screening detects 77-82% of Down syndrome cases with a 3-5% false-positive rate 1
• Traditional second-trimester quadruple screening has a 63% detection rate with a 10.8% false-positive rate 3
• NIPT requires only 1.1-2 amniocentesis procedures to confirm one affected pregnancy, versus 28-45 diagnostic procedures needed with traditional screening 1, 2

Technical Requirements and Timing

Optimal Testing Window:

• NIPT should be performed after ≥10 weeks gestation when fetal fraction typically reaches 10-15% of total cell-free DNA 4, 3
• A minimum fetal fraction of approximately 4% is required for reliable results 4, 3

Test Failure Rates:

• Approximately 1% of samples result in "no-call" outcomes, most commonly due to insufficient fetal fraction 1, 4, 3
• High maternal BMI is strongly associated with low fetal fraction, leading to test failure in up to 20% of such cases 4, 3
• Repeat testing at a later gestational age provides a result approximately 75-80% of the time 1, 2

Critical Limitations and Caveats

NIPT is a Screening Test, Not Diagnostic:

• All positive NIPT results require confirmatory diagnostic testing (amniocentesis or chorionic villus sampling) before any clinical decision-making 4, 3, 2
• False-negative results, though rare, can occur through biological mechanisms such as unusual chromosomal rearrangements 5

What NIPT Does NOT Detect:

• NIPT does not replace ultrasound for detection of structural fetal anomalies 4
• NIPT does not screen for neural tube defects 4, 2
• Rare autosomal trisomies (chromosomes other than 13,18,21) are not routinely reported 4

Factors That May Interfere:

• Vanishing twin gestation may affect interpretation accuracy; ACOG states NIPT should not be performed in such circumstances 1
• Known maternal malignancy is a relative contraindication due to somatic genomic aberrations in cancerous cells 1
• Some pregnancies with no-call results may have higher rates of fetal chromosome disorders, though this association is not universally confirmed 3, 2

Clinical Algorithm

For singleton pregnancies ≥10 weeks:

1. Offer NIPT as first-line screening for trisomy 21,18, and 13 1
2. If positive → proceed to diagnostic testing (amniocentesis/CVS) for confirmation 4, 3, 2
3. If negative → risk is reduced but not eliminated; continue routine prenatal care 2
4. If no-call → offer diagnostic testing or repeat NIPT at later gestational age 1, 2

For twin pregnancies:

• NIPT demonstrates equivalent performance to singletons for trisomy 21 detection 1, 2
• Sex chromosome aneuploidy screening may be limited depending on platform and chorionicity 4